<DOC>
	<DOCNO>NCT02615249</DOCNO>
	<brief_summary>48-hour application metal allergen patch test potential allergic response .</brief_summary>
	<brief_title>Clinical Evaluation Metal Panel Allergens : Dose Response Study</brief_title>
	<detailed_description>A 48-hour application ( approximate ) investigational allergen panel , excipient control correspond reference allergen apply skin human subject test potential positive allergic response . Test sit evaluate 3-4 , 7-8 , 10-14 19-23 day application . Ascending allergen dosage randomize within panel three different configuration randomly assign subject enter study . The investigator subject aware allergen patch test dos aware location individual allergen within panel .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . 18 year age old . 2 . Past positive patch test result within past 10 year ( one dilution series metal test study ) strong suspicion metal contact allergy base result Qualification Questionnaire . 3 . Unable become pregnant willing use acceptable method contraception prevent pregnancy female childbearing potential ; ( Inability become pregnant include male subject female subject postmenopausal least 1 year , surgically sterile hysterectomy , bilateral ovariectomy , uterine ablation bilateral tubal ligation . Acceptable method contraception include : 1 ) systemic birth control ; 2 ) double barrier method ; 3 ) intrauterine device ; 4 ) vasectomize partner ; 5 ) abstinence sexual intercourse . Subject must agree use acceptable contraception duration entire study . ) 4 . Understands sign approve Informed Consent form consistent institutional , local national regulation . 1 . Breastfeeding pregnant ( determined urine pregnancy test ) intend become pregnant course study . 2 . Topical treatment corticosteroid immunosuppressive agent near test area 14 day prior inclusion study . 3 . Systemic treatment corticosteroid ( equivalent &gt; 10 mg prednisone ) immunosuppressive agent 14 day prior inclusion study . Inhaled treatment permit . NOTE : Steroidal nose eye drop permit . 4 . Treatment ultraviolet ( UV ) light ( include tan ) 3 week prior inclusion study . 5 . Acute dermatitis outbreak dermatitis near test area back . 6 . Conditions ; fibromyalgia , chronic fatigue , depression , cognitive impairment , flulike symptom , diarrhea and/or headache without least one symptom related metal exposure list Section 10.1 physical examination 7 . Inability comply patch test study requirement include multiple return visit activity restriction ( e.g. , protect test panel excess moisture due shower vigorous activity ) . 8 . Participation clinical trial investigational drug , treatment device study 3 week prior inclusion study . 9 . An opinion Investigator deem potential subject noncompliant , unable return study visit complete study detail protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>